A rabbit model of ear otitis established using the Malassezia pachydermatis strain C23 from dogs

Nadezhda Sachivkina1,2, Arfenya Karamyan2, Olesya Petrukhina2

  • 1Department of Microbiology V.S. Kiktenko, Institute of Medicine, Peoples' Friendship University of Russia (RUDN University), Moscow, Russia.

Veterinary World
|December 28, 2023
PubMed
Abstract

Insights

A new rabbit model for fungal otitis was developed using a drug-resistant strain. This model shows rapid infection progression and is suitable for testing new antifungal drugs without immunosuppression.

Area of Science:

  • Veterinary Mycology
  • Infectious Diseases
  • Drug Development

Background:

  • Antifungal drug resistance is a growing concern in human and animal health.
  • Effective animal models are crucial for evaluating new antifungal treatments.
  • Existing models may require immunosuppression, complicating efficacy studies.

Purpose of the Study:

  • To establish a novel rabbit model of otitis externa.
  • To utilize an aggressive, multidrug-resistant Malassezia pachydermatis strain.
  • To assess the model's utility for antifungal drug testing without immunosuppression.

Main Methods:

  • Twenty adult male gray giant rabbits were inoculated with M. pachydermatis C23.
  • Clinical signs were monitored every five days.
  • Ear swabs and blood samples were collected for analysis.

Main Results:

  • The infection rapidly progressed, showing characteristic clinical signs.
  • No spontaneous recovery was observed within one month.
  • Deterioration was evidenced by changes in blood parameters.

Conclusions:

  • A rabbit otitis model was successfully established using a resistant fungal strain.
  • This model does not require immunosuppression, simplifying its use.
  • The model is valuable for testing novel antifungal agents against resistant fungal infections.